Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, UK.
Division of Endocrinology and Metabolism, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Greece; Division of Endocrinology, Metabolism and Diabetes, First Department of Paediatrics, National and Kapodistrian University of Athens Medical School, "Aghia Sophia" Children's Hospital, Athens, Greece.
Acta Biomed. 2020 Mar 19;91(1):165-175. doi: 10.23750/abm.v91i1.9244.
Over the last decade, we have witnessed a significant rise in the number of transgender young people seeking endocrine treatment, of which clinical service and gender dysphoria terminology have attempted to keep pace both in matching demand and better describing the condition. Although helpful guidelines for pubertal suppression and gender affirming hormones have been developed, uncertainties remain regarding treatment and monitoring during treatment, often because the clinical needs of the transgender population have outpaced medical expertise and training. Recently, multidisciplinary team work has evolved due to the increasing complexity of diagnostic and treatment decision-making and has been instrumental in creating a unique service with input from a range of specialists. In this article, the current approach in clinical management of adolescents with gender dysphoria is reviewed, with focus on the endocrine aspect of care in children and adolescents. Questions on what defines optimal clinical care of children and adolescents with gender dysphoria remain and should be the focus of future research.
在过去的十年中,我们见证了寻求内分泌治疗的跨性别年轻人数量的显著增加,其中临床服务和性别焦虑症术语都试图在满足需求和更好地描述病情方面跟上步伐。尽管已经制定了青春期抑制和性别肯定激素治疗的有用指南,但在治疗期间的治疗和监测方面仍存在不确定性,这通常是因为跨性别群体的临床需求超过了医学专业知识和培训。最近,由于诊断和治疗决策的日益复杂,多学科团队合作已经发展起来,并从一系列专家那里获得了独特服务的投入。本文回顾了目前对性别焦虑症青少年的临床管理方法,重点关注儿童和青少年内分泌方面的护理。关于什么是儿童和青少年性别焦虑症最佳临床护理的问题仍然存在,应该成为未来研究的重点。